340 - Chemical biology and drug discovery in infectious disease

Session Chair(s)

• Anand Balakrishnan

  Presenting Author
  Enanta Pharmaceuticals, Inc

Presentations:

• 4:30 PM – 4:45 PM

  Molecular Basis for Antiviral Action of EDP-235: A Potent and Selective SARS-CoV-2 3CLpro Inhibitor for the Treatment of Covid 19
  

  Presenting Author: Anand Balakrishnan – Enanta Pharmaceuticals, Inc
• 4:45 PM – 5:00 PM

  Efficient Incorporation and Template-Dependent Polymerase Inhibition are Major Determinants for the Broad-Spectrum Antiviral Activity of Remdesivir
  

  Presenting Author: Calvin Gordon – Department of Medical Microbiology and Immunology, University of Alberta
• 5:00 PM – 5:15 PM

  Modulation of lysosomal function as a therapeutic approach for coronaviral infections
  

  Presenting Author: Travis Lear – University of Pittsburgh
• 5:15 PM – 5:30 PM

  Antisense Molecules Designed to Target SARS-CoV-2 are Nontoxic to the Host in a Murine Model
  

  Presenting Author: Colleen McCollum – University of Colorado Boulder